ASCO22 - Highlights longtumoren

Koos van der Hoeven bespreekt met Egbert Smit ontwikkelingen bij longkanker. Aan bod komen onder andere een meta-analyse naar chemo-immunotherapie versus immunotherapie bij gevorderd NSCLC, nieuwe ontwikkelingen op het gebied van KRAS-remmers, de combinatie van immunotherapie en ramucirumab bij gevorderde NSCLC en de neo-adjuvante behandeling met immunotherapie.

Episode metadata supplied by the publisher feed · Published Jun 9, 2022

Embed this episode

Attribution link and audio player

Ready to play

ASCO22 - Highlights longtumoren

0:00 23:42

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncologie.nu?

This episode is 23 minutes long.

When was this Oncologie.nu episode published?

This episode was published on June 9, 2022.

Can I download this Oncologie.nu episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!